[December 09, 2016]

Hepatitis C Virus Envelope Protein E2 - Pipeline Review, H2 2016 - Research and Markets

Research and Markets has announced the addition of the "Hepatitis C Virus Envelope Protein E2 - Pipeline Review, H2 2016" report to their offering.

The report provides comprehensive information on the Hepatitis C Virus Envelope Protein E2 , targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Hepatitis C Virus Envelope Protein E2 targeted therapeutics development and features dormant and discontinued projects.

Key Topics Covered:

1. Introduction
2. Hepatitis C Virus Envelope Protein E2 Overview
3. Therapeutics Development
4. Pipeline Products for Hepatitis C Virus Envelope Protein E2 - Overview
5. Pipeline Products for Hepatitis C Virus Envelope Protein E2 - Comparative Analysis
6. Hepatitis C Virus Envelope Protein E2 - Therapeutics under Development by Companies
7. Hepatitis C Virus Envelope Protein E2 - Therapeutics under Investigation by Universities/Institutes
8. Hepatitis C Virus Envelope Protein E2 Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. Hepatitis C Virus Envelope Protein E2 - Products under Development by Companies
13. Hepatitis C Virus Envelope Protein E2 - Products under Investigation by Universities/Institutes
14. Hepatitis C Virus Envelope Protein E2 - Companies Involved in Therapeutics Development

• Aviragen Therapeutics, Inc.
• Integrated BioTherapeutics, Inc.

For more information about this report visit http://www.researchandmarkets.com/research/dd3pk5/hepatitis_c_virus

View source version on businesswire.com: http://www.businesswire.com/news/home/20161209005471/en/

[ Back To TMCnet.com's Homepage ]